Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2012

Open Access 01-12-2012 | Research

PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells

Authors: Xiao-Fen Lai, Cong-Xiang Shen, Zhong Wen, Yu-Hong Qian, Chao-Sheng Yu, Jun-Qi Wang, Ping-Neng Zhong, Hai-Li Wang

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2012

Login to get access

Abstract

Background

Human interacting protein X1 (PinX1) has been identified as a critical telomerase inhibitor and proposed to be a putative tumor suppressor gene. Loss of PinX1 has been found in a large variety of malignancies, however, its function in inhibiting telomerase activity of tumor cells is not well documented. Here we show that PinX1 is essential for down-regulation telomerase activity of nasopharyngeal carcinoma.

Methods

Expression vectors of human PinX1 (pEGFP-C3-PinX1) and its small interfering RNA (PinX1-FAM-siRNA) were constructed and transfected into NPC. Their effects on mRNA of telomerase catalytic subunit (hTERT), telomerase activity, cell proliferation, cell migration, wound healing, cell cycles and apoptosis were examined using semi-quantitative RT-PCR, stretch PCR, MTT assay, Transwell, scratch assay and flow cytometry, respectively.

Results

Transfection of pEGFP-C3-PinX1 and PinX1-FAM-siRNA increased and reduced PinX1 mRNA by 1.6-fold and 70%, respectively. Over-expression of PinX1 decreased hTERT mRNA by 21%, reduced telomerase activity, inhibited cell growth, migration and wound healing ability, arrested cells in G0/G1 phase, and increased apoptotic index. In contrast, down-regulation of PinX1 did not alter the above characteristics.

Conclusions

PinX1 may play important roles in NPC proliferation, migration and apoptosis and has application potential in tumor-targeted gene therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wen Z, Xiao JY, Tang FQ, Chen BL: The expression of telomerase and telomerase RNA in nasopharyngeal carcinoma (NPC) and HNE1 cell lines of NPC. Chin Med J. 2000, 113 (6): 525-528.PubMed Wen Z, Xiao JY, Tang FQ, Chen BL: The expression of telomerase and telomerase RNA in nasopharyngeal carcinoma (NPC) and HNE1 cell lines of NPC. Chin Med J. 2000, 113 (6): 525-528.PubMed
2.
go back to reference Wen Z, Xiao JY, Tian YQ, Chen BL: Down-regulation of telomerase and its RNA and apoptosis in HNE1 cell lines of nasopharyngeal carcinoma induced by hTR anti-sense oligo-nucleotide. Int J Mod Cancer Ther. 2000, 3 (1): 77-81. Wen Z, Xiao JY, Tian YQ, Chen BL: Down-regulation of telomerase and its RNA and apoptosis in HNE1 cell lines of nasopharyngeal carcinoma induced by hTR anti-sense oligo-nucleotide. Int J Mod Cancer Ther. 2000, 3 (1): 77-81.
3.
go back to reference Tian YQ, Wen Z, Xiao JY, Zhao SP, Tang FQ: Apoptosis in HNE1 cell lines of NPC induced by hTR anti-sense oligo-nucleotide. Chinese J Oto-rhino-laryng-skull Base Surg. 1999, 5 (4): 193-196. Tian YQ, Wen Z, Xiao JY, Zhao SP, Tang FQ: Apoptosis in HNE1 cell lines of NPC induced by hTR anti-sense oligo-nucleotide. Chinese J Oto-rhino-laryng-skull Base Surg. 1999, 5 (4): 193-196.
4.
go back to reference He DM, Zhang Y: Inhibition of Leukemic Cell Telomerase Activity by Antisense Phosphorothioate Oligodeoxynucleotides. The Chinese-German J Clin Oncol. 2002, 1 (2): 104-106. 10.1007/BF02851746.CrossRef He DM, Zhang Y: Inhibition of Leukemic Cell Telomerase Activity by Antisense Phosphorothioate Oligodeoxynucleotides. The Chinese-German J Clin Oncol. 2002, 1 (2): 104-106. 10.1007/BF02851746.CrossRef
5.
go back to reference Mu SF, Wen Z, Guo MH, Xie MQ: Guan XFg, Shen CX: TK gene targeted therapy mediated by the human telomerase promoter for transplanted tumor of nasopharyngeal carcinoma in vivo in nude mouse. Med J Chinese People's Liberation Army. 2009, 34 (2): 155-158. Mu SF, Wen Z, Guo MH, Xie MQ: Guan XFg, Shen CX: TK gene targeted therapy mediated by the human telomerase promoter for transplanted tumor of nasopharyngeal carcinoma in vivo in nude mouse. Med J Chinese People's Liberation Army. 2009, 34 (2): 155-158.
6.
go back to reference Shen CX, Wen Z, Qian YH, Guan XF, Mu SF: Enhanced thymidine kinase gene vector and its killing effect on nasopharyngeal carcinoma in vitro and in vivo. Chinese J Oto-rhino-laryng Head and Neck Surg. 2010, 45 (5): 414-419. Shen CX, Wen Z, Qian YH, Guan XF, Mu SF: Enhanced thymidine kinase gene vector and its killing effect on nasopharyngeal carcinoma in vitro and in vivo. Chinese J Oto-rhino-laryng Head and Neck Surg. 2010, 45 (5): 414-419.
7.
go back to reference Shen CX, Wen Z, Qian YH, Mu SF, Guan XF: Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer. J Exp Clin Cancer Res. 2010, 13: 29-94. Shen CX, Wen Z, Qian YH, Mu SF, Guan XF: Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer. J Exp Clin Cancer Res. 2010, 13: 29-94.
8.
go back to reference Kondo T, Oue N, Mitani Y, Kuniyasu H, Noguchi T, Kuraoka K, Nakayama H, Yasui W: Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. Oncogene. 2005, 24 (1): 157-164. 10.1038/sj.onc.1207832.CrossRefPubMed Kondo T, Oue N, Mitani Y, Kuniyasu H, Noguchi T, Kuraoka K, Nakayama H, Yasui W: Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. Oncogene. 2005, 24 (1): 157-164. 10.1038/sj.onc.1207832.CrossRefPubMed
9.
go back to reference Ma Y, Wu L, Liu C, Xu L, Li D, Li JC: The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population. J Cancer Res Clin. 2009, 135 (3): 431-437. 10.1007/s00432-008-0471-6.CrossRef Ma Y, Wu L, Liu C, Xu L, Li D, Li JC: The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population. J Cancer Res Clin. 2009, 135 (3): 431-437. 10.1007/s00432-008-0471-6.CrossRef
10.
go back to reference Liao C, Zhao MJ, Zhao J, Jia D, Song H, Li ZP: Over-expression of LPTS-L in hepatocellular carcinoma cell line SMMC-7721 induces crisis. World J Gastroenterol. 2002, 8 (6): 1050-1052.PubMed Liao C, Zhao MJ, Zhao J, Jia D, Song H, Li ZP: Over-expression of LPTS-L in hepatocellular carcinoma cell line SMMC-7721 induces crisis. World J Gastroenterol. 2002, 8 (6): 1050-1052.PubMed
11.
go back to reference Liao C, Zhao M, Song H, Uchida K, Yokoyama KK, Li T: Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma. Hepatology. 2000, 32 (4 Pt 1): 721-727.CrossRefPubMed Liao C, Zhao M, Song H, Uchida K, Yokoyama KK, Li T: Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma. Hepatology. 2000, 32 (4 Pt 1): 721-727.CrossRefPubMed
12.
go back to reference Sun J, Huang H, Zhu Y, Lan J, Li J, Lai X, Yu J: The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and--resistant acute promyelocytic leukemia cells. Int J Hematol. 2005, 82 (3): 215-223. 10.1532/IJH97.A10420.CrossRefPubMed Sun J, Huang H, Zhu Y, Lan J, Li J, Lai X, Yu J: The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and--resistant acute promyelocytic leukemia cells. Int J Hematol. 2005, 82 (3): 215-223. 10.1532/IJH97.A10420.CrossRefPubMed
13.
go back to reference Sun J, Tan YM, Huang H, Zhu YY, Lan JP, Lai XY: Expression of telomerase inhibitor Pinx1 in leukemia cells and its correlation with telomerase activity. Chinese J Pahophysiology. 2006, 22 (9): 1725-1728. Sun J, Tan YM, Huang H, Zhu YY, Lan JP, Lai XY: Expression of telomerase inhibitor Pinx1 in leukemia cells and its correlation with telomerase activity. Chinese J Pahophysiology. 2006, 22 (9): 1725-1728.
14.
go back to reference Hawkins GA, Chang BL, Zheng SL, Isaacs SD, Wiley KE, Bleecker ER, Walsh PC, Meyers DA, Xu J, Isaacs WB: Mutational analysis of PINX1 in hereditary prostate cancer. Prostate. 2004, 60 (4): 298-302. 10.1002/pros.20075.CrossRefPubMed Hawkins GA, Chang BL, Zheng SL, Isaacs SD, Wiley KE, Bleecker ER, Walsh PC, Meyers DA, Xu J, Isaacs WB: Mutational analysis of PINX1 in hereditary prostate cancer. Prostate. 2004, 60 (4): 298-302. 10.1002/pros.20075.CrossRefPubMed
15.
go back to reference Akiyama Y, Maesawa C, Wada K, Fujisawa K, Itabashi T, Noda Y, Honda T, Sato N, Ishida K, Takagane A, Saito K, Masuda T: Human PinX1, a potent telomerase inhibitor, is not involved in human gastrointestinal tract carcinoma. Oncol Rep. 2004, 11 (4): 871-874.PubMed Akiyama Y, Maesawa C, Wada K, Fujisawa K, Itabashi T, Noda Y, Honda T, Sato N, Ishida K, Takagane A, Saito K, Masuda T: Human PinX1, a potent telomerase inhibitor, is not involved in human gastrointestinal tract carcinoma. Oncol Rep. 2004, 11 (4): 871-874.PubMed
16.
go back to reference Chang Q, Pang JC, Li J, Hu L, Kong X, Ng HK: Molecular analysis of PinX1 in medulloblastomas. Int J Cancer. 2004, 109 (2): 309-314. 10.1002/ijc.11689.CrossRefPubMed Chang Q, Pang JC, Li J, Hu L, Kong X, Ng HK: Molecular analysis of PinX1 in medulloblastomas. Int J Cancer. 2004, 109 (2): 309-314. 10.1002/ijc.11689.CrossRefPubMed
17.
go back to reference Yuan K, Li N, Jiang K, Zhu TG, Huo YD, Wang C, Lu J, Shaw A, Thomas K, Zhang JC, Mann D, Liao J, Jin CJ, Yao XB: PinX1 is a novel microtubule-binding protein essential for accurate chromosome segregation. J Biol Chem. 2009, 284 (34): 23072-23082. 10.1074/jbc.M109.001990.PubMedCentralCrossRefPubMed Yuan K, Li N, Jiang K, Zhu TG, Huo YD, Wang C, Lu J, Shaw A, Thomas K, Zhang JC, Mann D, Liao J, Jin CJ, Yao XB: PinX1 is a novel microtubule-binding protein essential for accurate chromosome segregation. J Biol Chem. 2009, 284 (34): 23072-23082. 10.1074/jbc.M109.001990.PubMedCentralCrossRefPubMed
18.
go back to reference Klingelhutz AJ: The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Anticancer Res. 1999, 19 (6A): 4823-4830.PubMed Klingelhutz AJ: The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Anticancer Res. 1999, 19 (6A): 4823-4830.PubMed
19.
go back to reference Wang XW, Xiao JY, Zhao SP, Tian YQ, Wang GP: Expression of telomerase subunits and its relationship with telomerase activity in nasopharyngeal carcinoma. Natl Med J China. 2001, 9 (12): 553-556. Wang XW, Xiao JY, Zhao SP, Tian YQ, Wang GP: Expression of telomerase subunits and its relationship with telomerase activity in nasopharyngeal carcinoma. Natl Med J China. 2001, 9 (12): 553-556.
20.
go back to reference Liao C, Zhao MJ, Zhao J, Song H, Pineau P, Marchio A, Dejean A, Tiollais P, Wang HY, Li TP: Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma. World J Gastroenterol. 2003, 9 (1): 89-93.PubMed Liao C, Zhao MJ, Zhao J, Song H, Pineau P, Marchio A, Dejean A, Tiollais P, Wang HY, Li TP: Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma. World J Gastroenterol. 2003, 9 (1): 89-93.PubMed
21.
go back to reference Park WS, Lee JH, Park JY, Jeong SW, Shin MS, Kim HS, Lee SK, Lee SN, Lee SH, Park CG, Yoo NJ, Lee JY: Genetic analysis of the liver putative tumor suppressor (LPTS) gene in hepatocellular carcinomas. Cancer Lett. 2002, 178 (2): 199-207. 10.1016/S0304-3835(01)00841-2.CrossRefPubMed Park WS, Lee JH, Park JY, Jeong SW, Shin MS, Kim HS, Lee SK, Lee SN, Lee SH, Park CG, Yoo NJ, Lee JY: Genetic analysis of the liver putative tumor suppressor (LPTS) gene in hepatocellular carcinomas. Cancer Lett. 2002, 178 (2): 199-207. 10.1016/S0304-3835(01)00841-2.CrossRefPubMed
22.
go back to reference Zhang B, Bai YX, Ma HH, Feng F, Jin R, Wang ZL, Lin J, Sun SP, Yang P, Wang XX, Huang PT, Huang CF, Peng Y, Chen YC, Kung HF, Huang JJ: Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells. Cancer Res. 2009, 69 (1): 75-83. 10.1158/0008-5472.CAN-08-1393.CrossRefPubMed Zhang B, Bai YX, Ma HH, Feng F, Jin R, Wang ZL, Lin J, Sun SP, Yang P, Wang XX, Huang PT, Huang CF, Peng Y, Chen YC, Kung HF, Huang JJ: Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells. Cancer Res. 2009, 69 (1): 75-83. 10.1158/0008-5472.CAN-08-1393.CrossRefPubMed
23.
go back to reference Cai MY, Zhang B, He WP, Yang GF, Rao HL, Rao ZY, Wu QL, Guan XY, Kung HF, Zeng YX, Xie D: Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Sci. 2010, 101 (6): 1543-1549. 10.1111/j.1349-7006.2010.01560.x.CrossRefPubMed Cai MY, Zhang B, He WP, Yang GF, Rao HL, Rao ZY, Wu QL, Guan XY, Kung HF, Zeng YX, Xie D: Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Sci. 2010, 101 (6): 1543-1549. 10.1111/j.1349-7006.2010.01560.x.CrossRefPubMed
24.
go back to reference Wang HB, Wang XW, Zhou G, Wang WQ, Sun YG, Yang SM, Fang DC: PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway. J Gastrointest Surg. 2010, 14 (8): 1227-1234. 10.1007/s11605-010-1253-4.CrossRefPubMed Wang HB, Wang XW, Zhou G, Wang WQ, Sun YG, Yang SM, Fang DC: PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway. J Gastrointest Surg. 2010, 14 (8): 1227-1234. 10.1007/s11605-010-1253-4.CrossRefPubMed
25.
go back to reference Zhou XZ, Lu KP: The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell. 2001, 107 (3): 347-359. 10.1016/S0092-8674(01)00538-4.CrossRefPubMed Zhou XZ, Lu KP: The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell. 2001, 107 (3): 347-359. 10.1016/S0092-8674(01)00538-4.CrossRefPubMed
26.
go back to reference Banik SS, Counter CM: Counter, Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR. J Biol Chem. 2004, 279 (50): 51745-51748. 10.1074/jbc.M408131200.CrossRefPubMed Banik SS, Counter CM: Counter, Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR. J Biol Chem. 2004, 279 (50): 51745-51748. 10.1074/jbc.M408131200.CrossRefPubMed
27.
go back to reference Li N, Yuan K, Yan F, Huo Y, Zhu T, Liu X, Guo Z, Yao X: PinX1 is recruited to the mitotic chromosome periphery by Nucleolin and facilitates chromosome congression. Biochem Biophys Res Commun. 2009, 384 (1): 76-81. 10.1016/j.bbrc.2009.04.077.CrossRefPubMed Li N, Yuan K, Yan F, Huo Y, Zhu T, Liu X, Guo Z, Yao X: PinX1 is recruited to the mitotic chromosome periphery by Nucleolin and facilitates chromosome congression. Biochem Biophys Res Commun. 2009, 384 (1): 76-81. 10.1016/j.bbrc.2009.04.077.CrossRefPubMed
28.
go back to reference Chen G, Da L, Xu Y, Xu M, Song L, Li T, Zhao M: C-terminal amino acids 290-328 of LPTS/PinX1 confer telomerase inhibition. Biochem Biophys Res Commun. 2010, 398 (4): 683-689. 10.1016/j.bbrc.2010.06.136.CrossRefPubMed Chen G, Da L, Xu Y, Xu M, Song L, Li T, Zhao M: C-terminal amino acids 290-328 of LPTS/PinX1 confer telomerase inhibition. Biochem Biophys Res Commun. 2010, 398 (4): 683-689. 10.1016/j.bbrc.2010.06.136.CrossRefPubMed
Metadata
Title
PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells
Authors
Xiao-Fen Lai
Cong-Xiang Shen
Zhong Wen
Yu-Hong Qian
Chao-Sheng Yu
Jun-Qi Wang
Ping-Neng Zhong
Hai-Li Wang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2012
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-31-12

Other articles of this Issue 1/2012

Journal of Experimental & Clinical Cancer Research 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine